News
Kalydeco is used to treat cystic fibrosis in patients aged six years and above who have the G551D mutation in their gene for the protein called cystic fibrosis transmembrane conductance regulator (... Leggi tutto
Yervoy (ipilimumab) is the first drug ever shown to help late-stage melanoma patients live longer. However, it does not cure the disease.
"Late-stage melanoma is devastating, with very few treatment... Leggi tutto
BRUSSELS, Sept. 20, 2012 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced the launch of Plenadren® (hydrocortisone modified-release tablet) in Denmark, the first country in the... Leggi tutto
XALKORI® (crizotinib) is a prescription medicine used to treat non-small cell lung cancer (NSCLC) that is advanced or has spread to other parts of the body and is caused by a defect in a gene called... Leggi tutto
TARRYTOWN, N.Y., Nov. 27, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that EYLEA® (aflibercept) Injection has been approved by the European Commission for the... Leggi tutto
On October 26, 2009, the U.S. Food and Drug Administration granted accelerated approval to ofatumumab (Arzerra™, GlaxoSmithKline) for the treatment of patients with chronic lymphocytic leukemia (CLL... Leggi tutto
Basel, 21 November 2008
Roche today announced that the European Committee on Human Medicinal Products (CHMP) has given a positive recommendation for RoActemra (tocilizumab, known as Actemra outside... Leggi tutto
LITAK® (cladribine, 2-chloro-2'-deoxyadenosine, 2-CdA) is a purine nucleoside.
LITAK® is approved for recurrent or refractory follicular and diffuse non-Hodgkin's lymphoma, recurrent or refractory... Leggi tutto
1. Si vous ne possédez pas déjà un compte, demandez-le par le lien approprié. Un administrateur va vous activer l'accès.
[IMMAGINE1]
2. Connectez-vous avec le nom d'utilisateur et le mot de... Leggi tutto
Unipharma foi confirmado como o distribuidor exclusivo para a Itália e Vidaza Talidomida Pharmion.